Summary
The webpage provides important information regarding the withdrawal of the U.S. marketing authorization for a specific medication, including the cessation of its manufacturing license and the discontinuation of the associated Risk Evaluation and Mitigation Strategy (REMS). It serves as a resource for healthcare professionals, offering contact information for inquiries and reporting adverse reactions.
Based on content on blenrephcp.com
No similar companies found
We offer API access to our data.
7 of 8 checks passed
Label
Value
Active Dates
4.3 years — Since Sep 2020
Web Hosting
Platform
E-Mail Provider
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Pharmaceuticals
2. Pharmaceutical Preparation Manufacturing
Vendor
Source
TXT Record
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|